Home
>
National Drug Code (NDC)
>
CPDA-1
CPDA-1 - 0942-6321-04 - (Anticoagulant Citrate Phosphate Dextrose Adenine)
Drug Information of CPDA-1
| Product NDC: | 0942-6321 |
| Proprietary Name: | CPDA-1 |
| Non Proprietary Name: | Anticoagulant Citrate Phosphate Dextrose Adenine |
| Active Ingredient(s): | 9.6; 105; 1.12; 78; 921 mg/35mL; mg/35mL; g/35mL; mg/35mL; mg/35mL & nbsp; Anticoagulant Citrate Phosphate Dextrose Adenine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CPDA-1
| Product NDC: | 0942-6321 |
| Labeler Name: | Fenwal, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BN770420 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070601 |
Package Information of CPDA-1
| Package NDC: | 0942-6321-04 |
| Package Description: | 35 mL in 1 BAG (0942-6321-04) |
NDC Information of CPDA-1
| NDC Code | 0942-6321-04 |
| Proprietary Name | CPDA-1 |
| Package Description | 35 mL in 1 BAG (0942-6321-04) |
| Product NDC | 0942-6321 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Anticoagulant Citrate Phosphate Dextrose Adenine |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20070601 |
| Marketing Category Name | NDA |
| Labeler Name | Fenwal, Inc. |
| Substance Name | ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
| Strength Number | 9.6; 105; 1.12; 78; 921 |
| Strength Unit | mg/35mL; mg/35mL; g/35mL; mg/35mL; mg/35mL |
| Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
